Onderneming Immage Biotherapeutics Corp. Other OTC
Aandelen
IMMG
US45250J1007
Chemische grondstoffen
Vakgebied
Verkoop per activiteit
USD in miljoen | 2016 | Gewicht | Delta |
---|---|---|---|
Cancer Immunotherapy
nan
%
| 0 | nan % | - |
Verkoop per regio
USD in miljoen | 2016 | Gewicht | Delta |
---|---|---|---|
United States
nan
%
| 0 | nan % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mahesh Narayanan
FOU | Founder | 35 | 21-06-12 |
Anton Dormer
FOU | Founder | 60 | 21-06-12 |
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Anton Dormer
FOU | Founder | 60 | 21-06-12 |
Mahesh Narayanan
FOU | Founder | 35 | 21-06-12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 151 744 566 | 45 742 136 ( 30,14 %) | 0 | 30,14 % |
Bedrijfsgegevens
Immage Biotherapeutics Corp.
10411 Motor City Drive Suite 750
20817, Bethesda
+866 692 2939
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,50% | 103 mld. | |
-8,62% | 60,95 mld. | |
+72,86% | 49,09 mld. | |
+15,48% | 38,46 mld. | |
+3,64% | 32,09 mld. | |
+13,29% | 20,39 mld. | |
+12,53% | 16,78 mld. | |
+15,34% | 14,76 mld. | |
+0,39% | 13,73 mld. |